Medthority (@medthority) 's Twitter Profile
Medthority

@medthority

Medthority is a free eLearning platform for registered healthcare professionals, personalised to support your treatment decisions.

bit.ly/38gwj7x

ID: 35712161

linkhttp://www.medthority.com calendar_today27-04-2009 10:18:22

5,5K Tweet

2,2K Followers

1,1K Following

Medthority (@medthority) 's Twitter Profile Photo

From MS to migraine, uncover the latest insights this #WorldBrainDay. If you're a healthcare professional working in #neurology, don't miss free, expert learning resources for your specialty on Medthority. ow.ly/QJo150SBwU3 #eLearning #MedEd

From MS to migraine, uncover the latest insights this #WorldBrainDay. If you're a healthcare professional working in #neurology, don't miss free, expert learning resources for your specialty on Medthority. 

ow.ly/QJo150SBwU3

#eLearning #MedEd
Medthority (@medthority) 's Twitter Profile Photo

“We are living in a world where there will always be more than one possibility to get the patients through.” Watch Prof. Wojciech Jurczak present research highlights from #ASCO2024 and #EHA2024, and the implications for the future of #lymphoma treatment. ow.ly/jE8P50SK3O3

“We are living in a world where there will always be more than one possibility to get the patients through.” Watch Prof. Wojciech Jurczak present research highlights from #ASCO2024 and #EHA2024, and the implications for the future of #lymphoma treatment.

ow.ly/jE8P50SK3O3
Medthority (@medthority) 's Twitter Profile Photo

What progress has been made in risk assessment for venous thromboembolism in cancer patients? Unlock real-world evidence presented at #ISTH2024 on Medthority. ow.ly/Kw6H50SK4fU #haematology #MedEd #oncology

What progress has been made in risk assessment for venous thromboembolism in cancer patients? Unlock real-world evidence presented at #ISTH2024 on Medthority. 

ow.ly/Kw6H50SK4fU

#haematology #MedEd #oncology
Medthority (@medthority) 's Twitter Profile Photo

How do the costs of growth hormone deficiency (GHD) treatment differ across the globe? Read about the health economics of GHD care, plus an overview of approved treatments and related safety data. ow.ly/V0EH50SK4yJ #eLearning #MedEd #GrowthHormoneDeficiency #GHDtreatment

How do the costs of growth hormone deficiency (GHD) treatment differ across the globe? Read about the health economics of GHD care, plus an overview of approved treatments and related safety data. 

ow.ly/V0EH50SK4yJ

#eLearning #MedEd #GrowthHormoneDeficiency #GHDtreatment
Medthority (@medthority) 's Twitter Profile Photo

What investigational treatments are in clinical development to help address unmet needs for moderate-to-severe ulcerative colitis? Access clinical guidelines and treatment information on Medthority. ow.ly/m9ih50SK51Z #eLearning #MedEd #IBD #gastroenterology

What investigational treatments are in clinical development to help address unmet needs for moderate-to-severe ulcerative colitis? Access clinical guidelines and treatment information on Medthority. 

ow.ly/m9ih50SK51Z

#eLearning #MedEd #IBD #gastroenterology
Medthority (@medthority) 's Twitter Profile Photo

How do you select the right biologic to optimise outcomes in plaque psoriasis? This #PsoriasisActionMonth, watch our expert roundtable discussion, chaired by Prof. Luis Puig, including insights on switching and combining therapies. Available on demand. ow.ly/7Mbf50SOZJZ

How do you select the right biologic to optimise outcomes in plaque psoriasis? This #PsoriasisActionMonth, watch our expert roundtable discussion, chaired by Prof. Luis Puig, including insights on switching and combining therapies. Available on demand.

ow.ly/7Mbf50SOZJZ
Medthority (@medthority) 's Twitter Profile Photo

Did you know? Once you have read all 4 articles in our series on menopause-related vasomotor symptoms (VMS), you can unlock exclusive content. Don’t miss expert interviews with Jewel Kling MD MPH, Ms.Medicine and Sheryl Kingsberg ow.ly/5Y3A50SP0Ms #WomensHealth #MedEd

Did you know? Once you have read all 4 articles in our series on menopause-related vasomotor symptoms (VMS), you can unlock exclusive content. Don’t miss expert interviews with <a href="/DrJewelKling/">Jewel Kling MD MPH</a>, <a href="/MsMedicine/">Ms.Medicine</a> and <a href="/SherylKingsberg/">Sheryl Kingsberg</a>

ow.ly/5Y3A50SP0Ms

#WomensHealth #MedEd
Medthority (@medthority) 's Twitter Profile Photo

What are the clinical barriers to uptake of clinical practice guidelines for mCRPC? Watch expert interview with Profs. Axel Merseburger and Neeraj Agarwal on key topics in mCRPC management #oncology #MedEd #eLearning Neeraj Agarwal, MD, FASCO Axel S. Merseburger ow.ly/2vbS50SSSIe

What are the clinical barriers to uptake of clinical practice guidelines for mCRPC? Watch expert interview with Profs. Axel Merseburger and Neeraj Agarwal on key topics in mCRPC management 

#oncology #MedEd #eLearning <a href="/neerajaiims/">Neeraj Agarwal, MD, FASCO</a> <a href="/amerseburger/">Axel S. Merseburger</a>

ow.ly/2vbS50SSSIe
Medthority (@medthority) 's Twitter Profile Photo

From real-world safety profiles to genomic crystal balls, get expert insights from #ESMO24. Find out more about treatment advances for early #BreastCancer and innovative approaches for metastatic and triple-negative breast cancers on Medthority. ow.ly/7uTS50SVIXz

From real-world safety profiles to genomic crystal balls, get expert insights from #ESMO24. Find out more about treatment advances for early #BreastCancer and innovative approaches for metastatic and triple-negative breast cancers on Medthority. 

ow.ly/7uTS50SVIXz
Medthority (@medthority) 's Twitter Profile Photo

How does telehealth-based palliative care impact quality of life for people with advanced non-small cell lung cancer, compared with in-person care? Read our latest article on new outcome data presented at #ASCOGU24, including results and next steps. ow.ly/2B4z50SWPha

How does telehealth-based palliative care impact quality of life for people with advanced non-small cell lung cancer, compared with in-person care? Read our latest article on new outcome data presented at #ASCOGU24, including results and next steps.

ow.ly/2B4z50SWPha
Medthority (@medthority) 's Twitter Profile Photo

A smartwatch has detected signs of moderate-to-severe obstructive sleep apnea in adults without a prior diagnosis. But how does the data compare with that obtained from polysomnography? And could it lead to earlier detection of undiagnosed OSA? ow.ly/9MYz50SWPvR

A smartwatch has detected signs of moderate-to-severe obstructive sleep apnea in adults without a prior diagnosis. But how does the data compare with that obtained from polysomnography? And could it lead to earlier detection of undiagnosed OSA?

ow.ly/9MYz50SWPvR
Medthority (@medthority) 's Twitter Profile Photo

Join Drs Stephen Ansell, Pier Luigi Zinzani, and John Kuruvilla for a live, virtual roundtable on the most impactful data presented at #ASCO24, #ESMO24 and #EHA24. 14 October 2024, 15:00–16:00 UTC ow.ly/ZXiA50SWQ0x

Join Drs Stephen Ansell, Pier Luigi Zinzani, and <a href="/DrJohnKuruvilla/">John Kuruvilla</a> for a live, virtual roundtable on the most impactful data presented at #ASCO24, #ESMO24 and #EHA24. 

14 October 2024, 15:00–16:00 UTC

ow.ly/ZXiA50SWQ0x
Medthority (@medthority) 's Twitter Profile Photo

What are effective treatment options for hidradenitis suppurativa (HS)? Access the latest information, including medical and surgical treatments as part of a treat-to-target approach, in our comprehensive HS Learning Zone ow.ly/Qsts50T1Zbg #HS #HidradenitisSuppurativa

What are effective treatment options for hidradenitis suppurativa (HS)? Access the latest information, including medical and surgical treatments as part of a treat-to-target approach, in our comprehensive HS Learning Zone

ow.ly/Qsts50T1Zbg

#HS #HidradenitisSuppurativa
Medthority (@medthority) 's Twitter Profile Photo

From novel therapies to patient-centred approaches, find out more about the latest advances in care for metastatic castration-resistant prostate cancer (mCRPC), with Profs. Axel Merseburger and Neeraj Agarwal ow.ly/W3Gm50T4X5g #ProstateCancer #oncology #MedEd

From novel therapies to patient-centred approaches, find out more about the latest advances in care for metastatic castration-resistant prostate cancer (mCRPC), with Profs. Axel Merseburger and Neeraj Agarwal  

ow.ly/W3Gm50T4X5g 

#ProstateCancer #oncology #MedEd
Medthority (@medthority) 's Twitter Profile Photo

Which treatment goals and targets have the most impact for people with ulcerative colitis (UC)? Get expert guidance from Dr Tim Raine on incorporating the latest therapeutic approaches into your practice ow.ly/ybiw50T1ZXz #MedEd #UCResearch #MedEd #UlcerativeColitis

Which treatment goals and targets have the most impact for people with ulcerative colitis (UC)? Get expert guidance from Dr Tim Raine on incorporating the latest therapeutic approaches into your practice

ow.ly/ybiw50T1ZXz 

#MedEd #UCResearch #MedEd #UlcerativeColitis
Medthority (@medthority) 's Twitter Profile Photo

Find out more about the current treatment landscape for #GrowthHormoneDeficiency (GHD), including the results of a Phase 3 study investigating the efficacy and safety of long-acting growth hormone (LAGH) versus daily growth hormone ow.ly/97am50T20ie #MedEd

Find out more about the current treatment landscape for #GrowthHormoneDeficiency (GHD), including the results of a Phase 3 study investigating the efficacy and safety of long-acting growth hormone (LAGH) versus daily growth hormone 

ow.ly/97am50T20ie

 #MedEd
Medthority (@medthority) 's Twitter Profile Photo

What language is most effective when discussing weight management with #Type2Diabetes patients? Tune into our ACCME-accredited podcast with Professors Melanie Davies and Rachel Batterham. Earn 1 #CME point! ow.ly/yulO50T8ACE #MedTwitter #NurseTwitter

What language is most effective when discussing weight management with #Type2Diabetes patients? Tune into our ACCME-accredited podcast with Professors Melanie Davies and Rachel Batterham. Earn 1 #CME point!

ow.ly/yulO50T8ACE

#MedTwitter #NurseTwitter
Medthority (@medthority) 's Twitter Profile Photo

How much do you know about minimising the accrual of irreversible organ damage in people with #Lupus? Get expert insights from Professors Antonis Fanouriakis, Hans-Joachim Anders and Edith Williams with our EACCME accredited webinar, and earn 1 #CME point ow.ly/GlSi50T8CQt

How much do you know about minimising the accrual of irreversible organ damage in people with #Lupus? Get expert insights from Professors Antonis Fanouriakis, Hans-Joachim Anders and Edith Williams with our EACCME accredited webinar, and earn 1 #CME point

ow.ly/GlSi50T8CQt
Medthority (@medthority) 's Twitter Profile Photo

Watch the latest updates in hidradenitis suppurativa (HS) from #EHSF24, with expert presentations from Dr Antonio Martorell, Dr Philippe Guillem, and Prof. Falk Bechara. Find out more about treatments, disease management, and pathophysiology ow.ly/IHTC50T8Ehy #MedTwitter

Watch the latest updates in hidradenitis suppurativa (HS) from #EHSF24, with expert presentations from Dr Antonio Martorell, Dr Philippe Guillem, and Prof. Falk Bechara. Find out more about treatments, disease management, and pathophysiology 

ow.ly/IHTC50T8Ehy

#MedTwitter
Medthority (@medthority) 's Twitter Profile Photo

Molecularly targeted therapies for lymphoma: what key data and future directions were presented at #ASCO24 and #EHA24? Watch expert insights presented by Professor Wojciech Jurczak, plus other highlights from this year’s major congresses ow.ly/bgGY50T8EER #MedTwitter

Molecularly targeted therapies for lymphoma: what key data and future directions were presented at #ASCO24 and #EHA24? Watch expert insights presented by Professor Wojciech Jurczak, plus other highlights from this year’s major congresses 

ow.ly/bgGY50T8EER

#MedTwitter